Guideline on acute cystitis (uncomplicated urinary tract infection) (ICD-10 code N30.0) for general practitioners

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Lower urinary tract infections are one of the most common reasons why women seek medical help, in particular from general practitioners/therapists. The guideline addresses the main issues of etiology, pathogenesis, diagnosis and treatment of acute cystitis and asymptomatic bacteriuria. Conditions that require referral of the patient to a specialized specialist for treatment are listed separately.

Full Text

Restricted Access

About the authors

L. A. Sinyakova

Russian Medical Academy of Continuous Professional Education

Email: kosovainga@mail.ru
ORCID iD: 0000-0003-2142-4382
Russian Federation, Moscow

Inga V. Kosova

Russian Medical Academy of Continuous Professional Education; V.P. Demikhov City Clinical Hospital of the Moscow Healthcare Department

Author for correspondence.
Email: kosovainga@mail.ru
ORCID iD: 0000-0002-0051-0583

Dr. Sci. (Med.), Urologist, Professor at the Department of Urology and Surgical Andrologyn

Russian Federation, Moscow; Moscow

O. B. Loran

Russian Medical Academy of Continuous Professional Education

Email: kosovainga@mail.ru
ORCID iD: 0000-0002-7531-1511
Russian Federation, Moscow

V. A. Barsegian

Russian Medical Academy of Continuous Professional Education

Email: kosovainga@mail.ru
ORCID iD: 0000-0003-0592-3181
Russian Federation, Moscow

References

  1. Niska R., Bhuiya F., Xu J. National hospital ambulatory medical care survey: 2007 emergency department summary. Natl Health Stat Report. 2010;(26):1–31.
  2. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–60. doi: 10.1038/nrurol.2010.19.
  3. Лопаткин Н.А., Деревянко И.И. Неосложненные и осложненные инфекции мочеполовых путей. Принципы антибактериальной терапии. Русский медицинский журнал. 1997;24:1579–88. [Lopatkin N.A., Derevyanko I.I. Uncomplicated and complicated urinary tract infections. Principles of antibacterial therapy. Russian medical journal. 1997;24:1579–88. (In Russ.)].
  4. Страчунский Л.С., Рафальский В.В., Сехин С.В., Абрарова Э.Р. Практические подходы к выбору антибиотиков при неосложненных инфекциях мочевыводящих путей. Урология. 2002;2:8–14. [Strachunsky L.S., Rafalsky V.V., Sekhin S.V., Abrarova E.R. Practical approaches to the choice of antibiotics for uncomplicated urinary tract infections. Urology. 2002;2:8–14. (In Russ.)].
  5. Моисеев С.В. Практические рекомендации по антибактериальной терапии и профилактике инфекций мочевыводящих путей с позиций доказательной медицины. Инфекции и антимикробная терапия. 2003;5(3):89–92. [Moiseev S.V. Practical recommendations for antibacterial therapy and prevention of urinary tract infections from the perspective of evidence-based medicine. Infections and antimicrobial therapy. 2003;5(3):89–92. (In Russ.)].
  6. Naber K.G. Optimal management of uncomplicated and complicated urinary tract infections. Adv Clin Exp Med. 1998;7:41–6.
  7. Hooton T.M., Scholes D., Hughes J., et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335(7):468–74. doi: 10.1056/NEJM199608153350703.
  8. Лоран О.Б. Инфекции мочевыводящих путей амбулаторных больных. Материалы симпозиума. М., 1999. С. 5–9. [Loran O.B. Urinary tract infections in outpatients. Proceedings of the symposium. M., 1999. P. 5–9. (In Russ.)].
  9. Zilberberg M.D., Shorr A.F. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009. Infect Control Hosp. Epidemiol. 2013; 34:940–46.
  10. Ny S., Edquist P., Dumpis U., et al. Antibiotic resistance of Escherichia coli from outpatient urinary tract infection in women in six European countries including Russia J Glob Antimicrob Resist. 2019 Jun:17:25–34. doi: 10.1016/j.jgar.2018.11.004.
  11. Hummers-Pradier E., Ohse A.M., Koch M., et al. Management of urinary tract infections in female general practice patients. Fam Pract. 2005;22:71–7.
  12. Зайцев А.В., Перепанова Т.С., Гвоздев, М.Ю. и др. Инфекции мочевыводящих путей. Методические рекомендации. М., 2017. 26 с. [Zaitsev A.V., Perepanova T.S., Gvozdev, M.Yu. and others. Urinary tract infections. Guidelines. M., 2017. 26 p. (In Russ.)].
  13. Перепанова Т.С., Синякова Л.А., Козлов Р.С. и др. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М., 2022. 126 с. [Perepanova T.S., Sinyakova L.A., Kozlov R.S. and others. Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs. Federal clinical guidelines. M., 2022. 126 p. (In Russ.)].
  14. Перепанова Т.С., Синякова Л.А., Локшин К.Л. Цистит у женщин: клинические рекомендации. Российское общество урологов. 2021. 35 с. [Perepanova T.S., Sinyakova L.A., Lokshin K.L. Cystitis in women: clinical recommendations. Russian Society of Urologists. 2021. 35 p. (In Russ.)].
  15. Bongkat G., Bartoletti R., Bruyere F., et al. EAU Guidelines on Urological Infections. Edn. presented at the EAU Annual Congress Milan, Italy. 2023. 84 р.
  16. Hooton T.M. Uncomplicated urinary tract infections. N Engl J Med. 2012;366:1028–37. doi: 10.1056/NEJMcp1104429.
  17. Перепанова Т.С. Неосложненная инфекция мочевых путей. В кн: «Рациональная фармакотерапия в урологии. Руководство для практикующих врачей». Под общ. ред. Н.А. Ло- паткина, Т.С. Перепановой, 2-е изд. исп., и доп. М., 2012. С. 303–18. [Perepanova T.S. Uncomplicated urinary tract infection. In the book: “Rational pharmacotherapy in urology. A Guide for Practicing Physicians». Under the general editorship of N.A. Lopatkin, T.S. Perepanova, 2nd ed. corrected and additional M., 2012. pp. 303–18. (In Russ.)].
  18. Палагин И.С., Сухорукова М.В., Дехнич А.В. и др. Антибиотикорезистентность возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового исследования «Дармис-2018». КМАХ. 2019;21(2):134–46. [Palagin I.S., Sukhorukova M.V., Dekhnich A.V. and others. Antibiotic resistance of pathogens of community-acquired urinary tract infections in Russia: results of the multicenter study “Darmis-2018”. KMAX. 2019;21(2):134–46. (In Russ.)].
  19. Набока Ю.Л., Коган М.И., Морданов С.В. и др. Бактериально-вирусная микробиота мочи при неосложнённой рецидивирующей инфекции нижних мочевых путей (пилотное исследование). Вестник урологии. 2019;7(4):13–9. [Naboka Yu.L., Kogan M.I., Mordanov S.V. et al. Bacterial-viral microbiota of urine in uncomplicated recurrent lower urinary tract infection (pilot study). Journal of Urology. 2019;7(4):13–9. (In Russ.)].
  20. Синякова Л.А., Лоран О.Б., Косова И.В. и др. Геморрагический цистит у женщин: диагностика и лечение. Экспериментальная и клиническая урология. 2020;13(5):92–8. [Sinyakova L.A., Loran O.B., Kosova I.V. and others. Hemorrhagic cystitis in women: diagnosis and treatment. Experimental and clinical urology. 2020;13(5):92–8. (In Russ.)].
  21. Кульчавеня Е.В., Чередниченко А.А., Баранчукова А.Г. Диагностика урогенитального туберкулеза. Урология. 2015;5:124–28. [Kulchavenya E.V., Cherednichenko A.A., Baranchukova A.G. Diagnosis of urogenital tuberculosis. Urology. 2015;5:124–28. (In Russ.)].
  22. Foxman B., et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151:1194–205. doi: 10.1093/oxfordjournals.aje.a010170.
  23. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis Clin North Am. 2014;28:1–13. doi: 10.1016/j.idc.2013.09.003
  24. Nicolle L. Empirical treatment of acute cystitis in women. Int J Antimicrob Agents. 2003;22(1):1–6. doi: 10.1016/s0924-8579(03)00101-8.
  25. Svanborg C., Hedlund M., Connell H., et al. Bacterial adherence and mucosal cytokine responses. Receptors and transmembrane signaling. Ann N Y Acad Sci. 1996;797:177–90. doi: 10.1111/j.1749-6632.1996.tb52959.x.
  26. Waldhuber A., Puthia M., Wieser A., et al. Analysis of the Virulence of Uropathogenic Escherichia coli Strain CFT073 in the Murine Urinary Tract. Bio-Protoc. 2017;7(3):e2129. doi: 10.21769/BioProtoc.2129.
  27. Apodaca G. The Uroepithelium: Not Just a Passive Barrier. Traffic. 2004;5:117–28. doi: 10.1046/j.1600-0854.2003.00156.x.
  28. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–84. doi: 10.1038/nrmicro3432.
  29. Asadi Karam M.R., Habibi M., Bouzari S. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol Immunol. 2019;108:56–67. doi: 10.1016/j.molimm.2019.02.007.
  30. Mestrovi´c T., et al. The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. Diagnostics (Basel.). 2021 Dec 22;11(1):7. doi: 10.3390/diagnostics11010007.
  31. Finer G., Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet. Infect Dis. 2004;4(10):631–35. doi: 10.1016/S1473-3099(04)01147-8.
  32. Czaja C.A., Stamm W.E., Stapleton A.E., et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis. 2009;200(4):528–36. doi: 10.1086/600385.
  33. Дж. Мерт. Consilium medicum. Урология. Приложение. 2003. С. 3–5. [John Mert. Consilium medicum. Urology (Application). 2003. P. 3–5. (In Russ.)].
  34. Alidjanov J.F., Abdufattaev U.A., Makhsudov S.A., et al. The acute cystitis symptom score for patient-reported outcome assessment. Urol Int. 2016;97:402–9. doi: 10.1159/000448591.
  35. Косова И.В. Роль урогенитальных инфекций в этиологии циститов и необструктивных пиелонефритов у женщин. Дисс. кандидат мед. наук. М., 2005. [Kosova I.V. The role of urogenital infections in the etiology of cystitis and non-obstructive pyelonephritis in women. Diss. Cand. of Med. Sciences. M., 2005. (In Russ.)].
  36. Pernille H., Lars B., Marjukka M., et al. Sampling of urine for diagnosing urinary tract infection in general practice - First-void or mid-stream urine? Prim. Health Care. 2019;37(1):113–19. doi: 10.1080/02813432.2019.1568708.
  37. de Lastours V., Foxman B. Urinary tract infection in diabetes: epidemiologic considerations. Curr Infect Dis Rep. 2014;16(1):389. doi: 10.1007/s11908-013-0389-2.
  38. Kranz J., Schmidt S., Lebert C., et al. Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients: update 2017 of the interdisciplinary AWMF S3 guideline. Urol. 2017;56:746–58. doi: 10.1007/s00120-017-0389-1.
  39. Anger J., Lee U., Ackerman A.L., et al. American Urological Association (AUA)/Canadian Urological Association (CUA). Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) “Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline”. 2019 American Urological Association Education and Research, Inc.®, 36 р.
  40. Страчунский Л.С., Рафальский В.В., Сехин С.В., Абрарова Э.Р Практические подходы к выбору антибиотиков при неосложненных инфекциях мочевыводящих путей. Урология. 2002;2:8–14. [Strachunsky L.S., Rafalsky V.V., Sekhin S.V., Abrarova E.R. Practical approaches to the selection of antibiotics for uncomplicated urinary tract infections. Urology. 2002;2:8–14. (In Russ.)].
  41. Ny S., Edquist P., Dumpis U., et al. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J Glob Antimicrob Resist. 2019;17:25–34. doi: 10.1016/j.jgar.2018.11.004.
  42. Johansen T.E.B., Livermore D.M., Gat T., et al. SURF (SUsceptibility and Resistance of uropathogens to Fosfomycin comparison with other antimicrobial agents): an international microbiological surveillance study. Poster presented at 40th Congress of the Societe International d’Urology. 2020 Oct. 10–11.
  43. Cai T., Tamanini I., Tascini C., et al. Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis. J Urol. 2020;203(3):570–78. doi: 10.1097/JU.0000000000000620.
  44. Falagas M.E., et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010;65:1862–77.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig.1

Download (219KB)
Indexing metadata

Copyright (c) 2024 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies